about
Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype.Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data.An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in TaiwanClinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US states.Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.Predicting costs with diabetes complications severity index in claims data.Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.Utilization of primary and obstetric care after medically complicated pregnancies: an analysis of medical claims data.Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.Impact of bariatric surgery on health care utilization and costs among patients with diabetesCollaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.The Value of Continuity between Primary Care and Surgical Care in Colon CancerFragmentation in specialist care and stage III colon cancerEmergency Room Utilization After Medically Complicated Pregnancies: A Medicaid Claims Analysis.Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure.Comparing Population-based Risk-stratification Model Performance Using Demographic, Diagnosis and Medication Data Extracted From Outpatient Electronic Health Records Versus Administrative Claims.Emergency department visits by adults for psychiatric medication adverse eventsEmergency department visits by children and adolescents for antipsychotic drug adverse eventsScreening and diagnosis of micronutrient deficiencies before and after bariatric surgery.Readmissions After Colon Cancer Surgery: Does It Matter Where Patients Are Readmitted?Effect of a "pill mill" law on opioid prescribing and utilization: The case of TexasImpact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysisLaboratory testing for and diagnosis of nutritional deficiencies in pregnancy before and after bariatric surgery.Risk of Gastrointestinal Bleeding Among Dabigatran Users - A Self Controlled Case Series Analysis.Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation.Quality indicators of laryngeal cancer care in commercially insured patients.Treatment, short-term outcomes, and costs associated with larynx cancer care in commercially insured patients.Effect of Direct-to-Consumer Advertising on Statin Use in the United States.Association of Transoral Robotic Surgery With Short-term and Long-term Outcomes and Costs of Care in Oropharyngeal Cancer Surgery.Identifying Consistent High-cost Users in a Health Plan: Comparison of Alternative Prediction Models.Has Choosing Wisely® affected rates of dual-energy X-ray absorptiometry use?Development of a claims-based risk score to identify obese individuals.Impact of abuse-deterrent OxyContin on prescription opioid utilization.Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.Defining and Assessing Geriatric Risk Factors and Associated Health Care Utilization Among Older Adults Using Claims and Electronic Health Records.Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance.Prevalence and treatment of pain in EDs in the United States, 2000 to 2010.Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study.Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis
P50
Q24634093-2650E185-9C83-42E7-AC27-67E5AA4BC18FQ30148705-913D185E-639C-441D-832F-B5828850F0EDQ30591556-D63AB37C-19EE-4D8C-BD5B-0BE5ECF4B4BEQ33524889-AD976E1B-8082-4279-8E4A-4988EE5F0BA1Q33692832-5BFFC8CA-FC37-4FA7-8EBA-F14056D519C4Q34035766-4ED89850-EC7F-4ABB-A878-70256A88033FQ34254795-B155CDB6-400A-4173-90FD-62B2A3A69174Q34489761-AF415D73-9307-4CC4-85D0-C016734346C0Q35086448-222C8BF7-A0ED-45D9-AD61-A46D844732A0Q35550900-39B20245-641C-424A-8226-EC4893A10592Q35619737-C40CCA67-1320-42EC-9A69-791CC59C0E91Q35625692-49D137F5-7C3A-42A6-8213-9155B7887D93Q36027984-0FE673E4-01BA-48D8-A760-6883859DD541Q36030874-244CF715-9A3D-4979-B575-15F9AB968958Q36108602-AF3BC28C-F78E-4F9C-AE96-5B9CA289FD18Q36262403-70F06C72-5225-44FC-8171-290201456797Q36396839-BA4A0244-F26E-4F09-B43B-7C45A53CB00FQ36436410-CC8CB6D3-EAEB-4950-9D33-FC236ACE5AF8Q36494663-0B510F60-A585-494E-9ABD-2EF91CA53960Q37086448-77BECB58-EF92-4DF9-AFDD-AE849085E5EDQ37117855-6B785992-9957-4C1F-9B43-1E8FED3BDDB8Q37157553-6F9983A9-701A-4C86-A182-6A048FD0EE58Q37176971-048A7D32-B8B6-4E2F-AD8B-4B4AD6FBC3D7Q37579757-3C2E6B45-3B3B-4B6F-B961-3A04D7E93102Q37595293-B6C9A1D0-3B2E-497E-8A61-62C15F3E2810Q38621354-960D5194-1B60-43FC-A7F0-41A8F1CB598AQ38688633-CBE357E2-0D0C-40C4-B3D6-BC07844E8BE8Q38689797-B8E45554-77CB-4684-84C9-DCDD5EA4075FQ38734098-76E02677-1B32-435B-921D-D912BE44D979Q38867075-3F1468E2-16F6-4487-A45D-A51E3E72C74EQ39667438-3093EC9D-3443-44BC-9508-15ACC54EFB57Q40010443-CAC2CF4A-44EB-4CB1-93FF-A32465336F5BQ43656449-867F776E-38B6-400F-B0BA-9A77ADFD40CAQ44348158-A9BE7DD3-D61F-42AF-9F5D-82C0331B31E7Q46501184-158C4FF2-1648-4843-8204-99217BD7DFCDQ50042464-AC4C2E71-32F2-48B4-A5BF-47FF1AD886F9Q50073950-39A4E8B0-B675-4BDD-A838-3E17810BAC9CQ50658587-005F9164-D180-4C9C-9F89-6904E275651DQ55225065-2023D37A-BE89-4872-888F-F8C29AAB2630Q56551930-8AEF7419-E47C-4C8D-ADB6-D1B0FD7681C5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hsien-Yen Chang
@ast
Hsien-Yen Chang
@en
Hsien-Yen Chang
@es
Hsien-Yen Chang
@nl
type
label
Hsien-Yen Chang
@ast
Hsien-Yen Chang
@en
Hsien-Yen Chang
@es
Hsien-Yen Chang
@nl
prefLabel
Hsien-Yen Chang
@ast
Hsien-Yen Chang
@en
Hsien-Yen Chang
@es
Hsien-Yen Chang
@nl
P106
P1153
30067521000
P31
P496
0000-0002-7997-4822